Logo image of NAI.AS

NEW AMSTERDAM INVEST NV (NAI.AS) Stock Fundamental Analysis

AMS:NAI - Euronext Amsterdam - NL0015000CG2 - Common Stock - Currency: EUR

9.45  0 (0%)

Fundamental Rating

1

Overall NAI gets a fundamental rating of 1 out of 10. We evaluated NAI against 0 industry peers in the Unkown industry. NAI may be in some trouble as it scores bad on both profitability and health. NAI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NAI had positive earnings in the past year.
NAI had a positive operating cash flow in the past year.
NAI.AS Yearly Net Income VS EBIT VS OCF VS FCFNAI.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

Industry RankSector Rank
ROA 1.94%
ROE 5.76%
ROIC 3.79%
ROA(3y)-2.71%
ROA(5y)N/A
ROE(3y)-3.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NAI.AS Yearly ROA, ROE, ROICNAI.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

Industry RankSector Rank
OM 55.94%
PM (TTM) 23.82%
GM 67.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NAI.AS Yearly Profit, Operating, Gross MarginsNAI.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NAI is destroying value.
The number of shares outstanding for NAI remains at a similar level compared to 1 year ago.
Compared to 1 year ago, NAI has a worse debt to assets ratio.
NAI.AS Yearly Shares OutstandingNAI.AS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M 4M 5M
NAI.AS Yearly Total Debt VS Total AssetsNAI.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

NAI has an Altman-Z score of 0.48. This is a bad value and indicates that NAI is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of NAI is 22.91, which is on the high side as it means it would take NAI, 22.91 years of fcf income to pay off all of its debts.
NAI has a Debt/Equity ratio of 1.50. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 22.91
Altman-Z 0.48
ROIC/WACC0.62
WACC6.07%
NAI.AS Yearly LT Debt VS Equity VS FCFNAI.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

NAI has a Current Ratio of 0.63. This is a bad value and indicates that NAI is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.63 indicates that NAI may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.63
NAI.AS Yearly Current Assets VS Current LiabilitesNAI.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 154.05% over the past year.
Looking at the last year, NAI shows a very strong growth in Revenue. The Revenue has grown by 142.30%.
EPS 1Y (TTM)154.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130.42%
Revenue 1Y (TTM)142.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%62.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAI.AS Yearly Revenue VS EstimatesNAI.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.17, the valuation of NAI can be described as rather expensive.
When comparing the Price/Earnings ratio of NAI to the average of the S&P500 Index (26.29), we can say NAI is valued slightly cheaper.
Industry RankSector Rank
PE 18.17
Fwd PE N/A
NAI.AS Price Earnings VS Forward Price EarningsNAI.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 15.64
EV/EBITDA 18.53
NAI.AS Per share dataNAI.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEW AMSTERDAM INVEST NV

AMS:NAI (5/29/2025, 7:00:00 PM)

9.45

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap48.86M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.39
Dividend Growth(5Y)N/A
DP76.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.17
Fwd PE N/A
P/S 4.4
P/FCF 15.64
P/OCF 15.64
P/B 1.06
P/tB 1.06
EV/EBITDA 18.53
EPS(TTM)0.52
EY5.5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.6
FCFY6.39%
OCF(TTM)0.6
OCFY6.39%
SpS2.15
BVpS8.89
TBVpS8.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.94%
ROE 5.76%
ROCE 4.98%
ROIC 3.79%
ROICexc 3.95%
ROICexgc 3.95%
OM 55.94%
PM (TTM) 23.82%
GM 67.96%
FCFM 28.1%
ROA(3y)-2.71%
ROA(5y)N/A
ROE(3y)-3.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 22.91
Debt/EBITDA 11.06
Cap/Depr 20%
Cap/Sales 0.01%
Interest Coverage 2.36
Cash Conversion 50.22%
Profit Quality 117.98%
Current Ratio 0.63
Quick Ratio 0.63
Altman-Z 0.48
F-Score5
WACC6.07%
ROIC/WACC0.62
Cap/Depr(3y)16.98%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)154.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130.42%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)142.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%62.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y400.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y192.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y192.51%
OCF growth 3YN/A
OCF growth 5YN/A